维普中文期刊产品整合服务
157篇 您的检索式:作者名="ALLHAT"
    题名 作者 年代 出处 被引量
1Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic:the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial(ALLHAT)显示文摘ALLHAT Investigators 2002JAMA2002,288,23:1
2Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care:the antihypertensive and lipid-lowering treatment to prevent heart attack trial ( ALLHAT-LLT ) 显示文摘The ALLHAT officers and coordinators for the ALLHAT collaborative research group 2002JAMA2002,288,:1
3Major outcomes in high risk hypertensive patients randomized to angiotensin converting enzyme inhibitor or calcium channel blocker vs diuretic the antihypertensive and lipid lowering treatment to prevent heart at tack trial (ALLHAT) 显示文摘The ALLHAT officers and coordinators for t he ALL HAT collaborative research group 2002JAMA2002,288,23:1
4The Antihypertensive and Lipid-Lowering Treatment to Prevent Heatr Attack Trial Major outcomes in Moderately hypercholestetolemic,hypertensive patients randomized to Pravastatin vs usual care:The Antihypertensive and LipidLoweting Treatment to Prevent Heatr Attack Trial (ALLHATLLJ)显示文摘ALLHAT Officers and Coordiantors for the ALLHAT Collaborative Research Group 2002JAMA2002,288,:1
5Major outcomes in high-risk hypertensive patients randomized to angiotensin -converting enzyme inhibitor or calcium channel blocker vs diuretic:The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)显示文摘The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group 2002JAMA2002,288,:1
6Baseline Characterstics of Participants in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial ALLHAT 显示文摘 2001Hypertension2001,37,1:1
7Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic:the antihypertensive and lipid-lowering treatment to prevent heart attack trial(ALLHAT)显示文摘The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group 2002JAMA2002,288,:1
8Major outcomes in high-risk hypertensive patients randomized to angiotensin -convert- ing enzyme inhibitor or calcium channel blocker vs di- uretic the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT) 显示文摘The ALLHAT officers and coordinators for the ALLHAT collaborative research group 2002JAMA2002,288,23:1
9Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic显示文摘The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) 2002JAMA2002,288,:1
10Major outcomes in high risk hypertensive patients randomized to ACE inhibitor a calcium channel blocker vs diuretic2the antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT)显示文摘The ALLHAT officer and coordinators for the ALLHAT collaborative research group 2002JAMA2002,288,:1
11Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic : the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) 显示文摘The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group 2002JAMA2002,288,:1
12Major outcome in moderate hypercholesterolemic hypertensive patients randomized to pravastatin vs usual care:the Antihypertensive and Lipid-lowering Treatment to Prevent Heart Attack Trial(ALLHA-LLT)显示文摘The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group 2002JAMA2002,288,23:1
13Major outcomes in moderately hypercholesterolemic,hypertensive patients randomized to pravastatin vs usual care:The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)显示文摘ALLHAT officersand coordinators 2002JAMA2002,288,23:1
14Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitors and enzyme inhibitor or calcium channel blocker vs diuretic显示文摘 2002JAMA2002,288,:1
15Major outcomes in high-risk hypertensive patients randomized to angiotensin -converting enzyme inhibitor or calcium channel blocker vs diuretic:The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)显示文摘The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group 2002JAMA2002,288,:1
16Major outcomes in moderately hypercholesterolemic,hypertensive patients randomized to pravastatin vs usual care:The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)显示文摘ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group 2002JAMA2002,288,23:1
17Major outcomes in high-risk hypertensive patients randomised to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic:the Antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT)显示文摘 2002JAMA2002,288,:1
18Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic显示文摘The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group 2002JAMA2002,288,:1
19Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT) 显示文摘The ALLHAT Officers and coordinators for the ALLHAT Collaborative Research Group 2002JAMA2002,288,23:1
20Major outcomes in high-risk hypertensive patients randomised to angiotensin-converting enzyme inhibitor or calcium channel blockers vs diuretic: The Antihypertensive and Lipid-Lowering treatment prevent Heart Attack Trial (ALLHAT) 显示文摘The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group 2002JAMA2002,288,:1
返回顶部 每页显示:
共8页 首页 上一页 第1页 下一页 末页 /8 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费